Related Experiment Video

Updated: Mar 16, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.3K

A Comment on "Discovery and Characterization of AMPA Receptor Modulators Selective for TARP-γ8"

Jeffrey M Witkin1, Kevin M Gardinier2

  • 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana jwitkin@lilly.com.

The Journal of Pharmacology and Experimental Therapeutics
|August 17, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

8.1K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.6K

Related Experiment Videos

Last Updated: Mar 16, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.3K
A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

8.1K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

9.6K

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

6.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.0K

Articles linked to this work by shared authors, journal, and citation graph.

Low-impact ampakine CX717 exhibits promising therapeutic profile in adults with ADHD - A phase 2A clinical trial.

European journal of pharmacology·2025

Is there a continued need for behavioral pharmacology in the discovery and development of medicines?

The Journal of pharmacology and experimental therapeutics·2025

Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophrenia.

Journal of psychiatric research·2025

Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today.

Pharmacology, biochemistry, and behavior·2025

Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjects.

European journal of pharmacology·2025

Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy.

Pharmacology & therapeutics·2024

Impact of Δ9-tetrahydrocannabinol and oxycodone coadministration on measures of antinociception, dependence, circadian activity, and reward in mice.

The Journal of pharmacology and experimental therapeutics·2026

Repurposing ribavirin for oncology: Integrating metabolism, signaling, and translational control.

The Journal of pharmacology and experimental therapeutics·2026

Circular RNAs regulate the progression of pulmonary hypertension through distinct roles and mechanisms.

The Journal of pharmacology and experimental therapeutics·2026

US postmarketed drug removals: Analysis of discontinued and withdrawn drugs.

The Journal of pharmacology and experimental therapeutics·2026

RRx-001 sensitizes triple-negative breast cancer cells to oxaliplatin through apoptosis, cell cycle arrest, and immune modulation.

The Journal of pharmacology and experimental therapeutics·2026

Dynamic mechanistic dominance in fentanyl and polysubstance overdose: Implications for next-generation reversal.

The Journal of pharmacology and experimental therapeutics·2026

Five New Iridoids From the Leaves of Viburnum macrocephalum f. macrocephalum and Their Free Radical Scavenging Activity.

Chemistry & biodiversity·2026

Nanovesicle-formulated Sterculia coccinea Jack (hantap) leaf extract: Estrogen receptor-alpha molecular docking and cytotoxicity in Michigan Cancer Foundation-7 cells.

Journal of advanced pharmaceutical technology & research·2026

Tissue-specific untargeted 1H-NMR metabolomics reveals no adverse metabolic effects of daily intrabuccal cannabidiol (CBD) in healthy mice.

Frontiers in pharmacology·2026

Chemical profiling, biological evaluation, and QSAR-informed metabolite prioritization of Hypericum ekerii: a first report on antioxidant, enzyme inhibitory, and cytotoxic activities.

RSC advances·2026

Pharmacological activities of Xanthosoma sagittifolium (L.) Schott and Corchorus olitorius L. extracts in uterine leiomyoma: evidence from in vitro and in vivo approaches.

Frontiers in pharmacology·2026

Exploring the Interaction of Flavonoids Baicalein and Scutellarein With Human Serum Albumin: Spectroscopic and Computational Study.

ChemPlusChem·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us